Skip to main content
JAGX
NASDAQ Life Sciences

纳斯达克因报价价格不符合最低要求而通知Jaguar Health摘牌

feedReported by Wiseek News
Sentiment info
Negative
Importance info
9
Price
$0.642
Mkt Cap
$2.206M
52W Low
$0.56
52W High
$15.48
Market data snapshot near publication time

summarizeSummary

Jaguar Health收到来自纳斯达克的摘牌通知，因为其未能维持1.00美元的最低报价价格。由于最近的反向股票拆分，公司无法获得合规期，这使得情况更加严重，表明公司一直在努力满足上市要求。虽然公司打算提出上诉，但这一通知对其公开上市构成严重风险，可能会阻碍其筹集资金和维持投资者信心的能力。这一重大治理问题掩盖了最近的事件，例如收到300万美元的付款和Series O可转换优先股股息，凸显了公司金融和运营状况的岌岌可危。

在该公告发布时，JAGX的交易价格为$0.64，交易所为NASDAQ，所属行业为Life Sciences，市值约为$220.6万。 52周交易区间为$0.56至$15.48。 这则新闻被评估为消极市场情绪，重要性评分为9/10。 来源：Wiseek News。

show_chartPrice Chart

Share this article

Copied!

feed JAGX - Latest Insights

JAGX
Apr 27, 2026, 9:10 AM EDT
Filing Type: 8-K
Importance Score:
8
Jaguar Health Announces 1-for-35 Reverse Stock Split to Meet Nasdaq Listing Requirements
Sentiment: Negative
View Wiseek Article
JAGX
Apr 27, 2026, 9:00 AM EDT
Source: Access Newswire
Importance Score:
8
1-for-35 Reverse Stock Split Set for Jaguar Health as Nasdaq Grants Delisting Extension
Sentiment: Neutral
View Wiseek Article
JAGX
Apr 21, 2026, 8:22 AM EDT
Filing Type: PRE 14A
Importance Score:
10
Jaguar Health Seeks Shareholder Approval for Highly Dilutive $42.4M Financing to Address Capital Needs
Sentiment: Negative
View Wiseek Article
JAGX
Apr 21, 2026, 7:35 AM EDT
Filing Type: 8-K
Importance Score:
9
Stockholders Approve Massive Share Increase, Two Reverse Splits, and $10.8M Debt Conversion
Sentiment: Negative
View Wiseek Article
JAGX
Apr 13, 2026, 8:30 AM EDT
Source: Access Newswire
Importance Score:
7
Jaguar Health to Leverage AI, Pursue FDA Breakthrough Status for Crofelemer in Rare Disease
Sentiment: Positive
View Wiseek Article
JAGX
Apr 09, 2026, 5:04 PM EDT
Filing Type: 8-K
Importance Score:
9
Jaguar Health Believes It Has Regained Nasdaq Stockholders' Equity Compliance, Averting Delisting Threat
Sentiment: Positive
View Wiseek Article
JAGX
Apr 08, 2026, 8:30 AM EDT
Source: Access Newswire
Importance Score:
7
Jaguar Health Completes Pivotal Trial for Canine Diarrhea Drug Crofelemer, Eyes Full FDA Approval
Sentiment: Positive
View Wiseek Article
JAGX
Apr 07, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
9
Jaguar Health Reports Deepening Losses and Nasdaq Delisting Threat Amidst 2025 Financials
Sentiment: Negative
View Wiseek Article
JAGX
Apr 07, 2026, 6:10 AM EDT
Filing Type: 10-K
Importance Score:
9
Jaguar Health Faces Imminent Nasdaq Delisting, Warns of Going Concern Amidst Massive Potential Dilution
Sentiment: Negative
View Wiseek Article
JAGX
Mar 24, 2026, 5:06 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Jaguar Health Seeks Shareholder Approval for Massive Dilution, Two Extreme Reverse Stock Splits
Sentiment: Negative
View Wiseek Article